LogicBio Therapeutics, Inc.

Informe acción DB:0IF

Capitalización de mercado: €68.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

LogicBio Therapeutics Dirección

Dirección controles de criterios 1/4

Información clave

Fred Chereau

Chief Executive Officer (CEO)

US$2.2m

Compensación total

Porcentaje del salario del CEO24.3%
Permanencia del CEO6.6yrs
Participación del CEOn/a
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva3.4yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Fred Chereau en comparación con los beneficios de LogicBio Therapeutics?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021US$2mUS$543k

-US$40m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$36m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$2mUS$479k

-US$33m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$40m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$633kUS$510k

-US$40m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$29m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$2mUS$411k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$779kUS$385k

-US$8m

Compensación vs. Mercado: Fred's total compensation ($USD2.23M) is above average for companies of similar size in the German market ($USD433.84K).

Compensación vs. Ingresos: Fred's compensation has increased whilst the company is unprofitable.


CEO

Fred Chereau (55 yo)

6.6yrs

Permanencia

US$2,228,208

Compensación

Mr. Frederic Chereau, M.B.A., also known as Fred, is the Chairman of the Board of Coave Therapeutics since October 2022 and has been its Independent Non-Executive Director since October 2021. He has execut...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Frederic Chereau
President6.6yrsUS$2.23msin datos
Mark Kay
Co-Founderno dataUS$156.64k0%
$ 0
Daniel Gruskin
Chief Medical Officer2.4yrsUS$1.54m0%
$ 0
Leszek Lisowski
Co-Founder & Member of Scientific Advisory Boardno datasin datossin datos
Adi Barzel
Co-Founder8.3yrssin datossin datos
Joshua Blacher
Interim CFOless than a yearsin datossin datos
Matthias Hebben
Global VP & Head of Technology Development3.6yrssin datossin datos
Mariana Nacht
Chief Scientific Officer2yrsUS$1.34msin datos
Andrea Paul
General Counsel & Corporate Secretary1.5yrssin datossin datos
Grace Lochhead
VP & Head of Human Resources1.2yrssin datossin datos
Janice Olson
Senior Vice President of Strategy & Portfolio Management1.4yrssin datossin datos
Michael Franken
Chief Business Officer1.3yrssin datossin datos

1.8yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: 0IF's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Frederic Chereau
Presidentno dataUS$2.23msin datos
Mark Kay
Co-Founder6.8yrsUS$156.64k0%
$ 0
Leszek Lisowski
Co-Founder & Member of Scientific Advisory Boardno datasin datossin datos
Michael Wyzga
Independent Director4.2yrsUS$87.39k0%
$ 0
Richard Moscicki
Independent Chairman of the Board4.1yrsUS$113.64k0%
$ 0
Mark Enyedy
Independent Director2.7yrsUS$82.02k0%
$ 0
Markus Grompe
Member of Scientific Advisory Boardno datasin datossin datos
Leon Chen
Independent Director6.8yrsUS$81.14k0%
$ 0
J. Goater
Independent Director1.9yrsUS$76.77k0%
$ 0
Daphne Karydas
Independent Director1.9yrsUS$79.64k0%
$ 0
David Russell
Member of Scientific Advisory Boardno datasin datossin datos
Susan Kahn
Independent Directorless than a yearUS$40.31ksin datos

3.4yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: 0IF's board of directors are considered experienced (3.4 years average tenure).